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Insights into the phosphoryltransfer mechanism of human
thymidylate kinase gained from crystal structures of enzyme
complexes along the reaction coordinate
Nils Ostermann1, Ilme Schlichting1, Ralf Brundiers2, Manfred Konrad2, 
Jochen Reinstein1, Thomas Veit1, Roger S Goody1* and Arnon Lavie1†
Background: Thymidylate kinase (TMPK) is a nucleoside monophosphate
kinase that catalyzes the reversible phosphoryltransfer between ATP and TMP
to yield ADP and TDP. In addition to its vital role in supplying precursors for
DNA synthesis, human TMPK has an important medical role participating in the
activation of a number of anti-HIV prodrugs.
Results: Crystal structures of human TMPK in complex with TMP and ADP,
TMP and the ATP analog AppNHp, TMP with ADP and the phosphoryl analog
AlF3, TDP and ADP, and the bisubstrate analog TP5A were determined. The
conformations of the P-loop, the LID region, and the adenine-binding loop vary
according to the nature of the complex. Substitution of ADP by AppNHp results
in partial closure of the P-loop and the rotation of the TMP phosphate group to
a catalytically unfavorable position, which rotates back in the AlF3 complex to a
position suitable for in-line attack. In the fully closed state observed in the TP5A
and the TDP–ADP complexes, Asp15 interacts strongly with the 3′-hydroxyl
group of TMP.
Conclusions: The observed changes of nucleotide state and conformation
and the corresponding protein structural changes are correlated with
intermediates occurring along the reaction coordinate and show the sequence
of events occurring during phosphate transfer. The low catalytic activity of
human TMPK appears to be determined by structural changes required to
achieve catalytic competence and it is suggested that a mechanism might exist
to accelerate the activity.
Introduction
Phosphoryltransfer reactions are among the most
common reactions in biological systems and are catalyzed
by ubiquitous enzymes that are generally referred to as
kinases or phosphatases, or hydrolases if the acceptor is
water. Typically, nucleotides are the phosphoryl donors
of kinases. The range of phosphoryltransfer reactions cat-
alyzed by these kinases includes such processes as the
stepwise phosphorylation of nucleosides to nucleoside
monophosphates (NMPs), then to nucleoside diphos-
phates (NDPs), and ultimately to nucleoside triphos-
phates (NTPs). The cascade of kinases that activate
nucleosides to NTPs is of medical significance as it is
responsible for the activation of antiviral prodrugs such as
3′-azido-3′-deoxythymidine (AZT) and 2′,3′-didehydro-
2′,3′-dideoxythymidine (d4T). The conversion of these
compounds from the monophosphate metabolite to the
diphosphate is catalyzed by thymidylate kinase (EC
2.7.4.9, ATP:TMP phosphotransferase). Physiologically,
thymidylate kinase (TMPK) catalyzes the reversible
phosphorylation of thymidine monophosphate (TMP)
using adenosine triphosphate (ATP) as its preferred
phosphoryl donor [1] according to the following scheme:
TMP + ATP*Mg TDP + ADP*Mg
In contrast to other nucleoside monophosphate kinases
(NMPKs), TMPK is cell-cycle regulated with its expres-
sion limited to the S phase of cell replication [2,3]. The
location of TMPK at the junction of the de novo and
salvage pathways for thymidine triphosphate (TTP) syn-
thesis makes this enzyme essential for DNA replication.
Therefore, potent and selective inhibitors of human
TMPK could have a role in cancer chemotherapy. A pre-
requisite for the rational design of such compounds is a
detailed understanding of the catalytic machinery of
TMPK at the molecular level.
Yeast and Escherichia coli TMPK are globular dimeric pro-
teins with a similar fold to other NMPKs. Sequence
homology and biochemical data, corroborated by the pre-
viously determined structures of yeast [4] and E. coli [5]
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TMPK, demonstrate that three loops are crucial for the
function of this enzyme. The first is the highly conserved
P-loop motif [6] (consensus sequence GX1X2X3X4GKS/T,
in single-letter amino acid code), which binds and posi-
tions the α- and β-phosphoryl groups of the phosphoryl
donor (ATP) through interactions between amide back-
bone hydrogens and phosphate oxygen atoms. Unique to
TMPKs is an interaction between the P-loop (residues
13–17 of human TMPK) and the phosphoryl acceptor
(TMP) [4,5]. This is achieved through a hydrogen bond
between the 3′-hydroxyl group of TMP and a carboxylic
acid residue at position X2 of the P-loop motif. The exact
function of this residue is still unclear but it seems to be
very important for the catalytic mechanism of TMPK as
any mutation of this residue in either the yeast, human or
E. coli enzyme abolishes activity [7].
The second critical loop contains the DR(Y/H) motif char-
acteristic of TMPKs [8]. The aspartic acid residue (Asp96 in
the human enzyme) is important for the binding and posi-
tioning of the magnesium ion complexed to ATP. The adja-
cent arginine residue (Arg97) acts as a clamp to bring the
donor and acceptor nucleotides together by simultaneously
making an interaction to the phosphate group of TMP and
the γ-phosphate of ATP. The φ/ψ angles (80°/150°) of this
arginine residue place it in the disallowed area of the
Ramachandran plot (observed in all TMPK structures across
three species). The function of this backbone strain is still
unclear, but might be related to the catalytic importance of
this residue. The third loop is the so-called LID region
(residues 135–150). The LID is a flexible stretch that closes
on the phosphoryl donor when it binds.
NMPKs bind the acceptor and donor nucleotides (the
respective NMP as phosphoryl acceptor and in general
ATP as the phosphoryl donor) such that the phosphate
groups face each other. The kinetic mechanism of mouse
TMPK and the homologous guanylate kinase (GMPK)
and adenylate kinase (AMPK) has been shown to be
random bi-bi in which the nucleotides bind indepen-
dently of each other [9–11]. Crystal structures of substrate-
free AMPK and AMPK in complex with only one
substrate, both substrates or the bisubstrate inhibitor
AP5A showed that NMPKs undergo large conformational
changes upon substrate binding [12]. One can distinguish
between an open conformation without substrate, a par-
tially closed conformation with a single substrate and a
fully closed and active conformation in the presence of
both substrates (or in the presence of AP5A) [12]. In the
fully closed structures of AMPK — and analogous struc-
tures of uridylate kinase (UMPK) — phosphoryl groups of
both substrates interact with arginine sidechains of the
LID region, revealing their importance in catalyzing phos-
phoryltransfer [13–15]. Eukaryotic TMPKs seem to work
differently, however, as they possess no basic residues in
the LID that could interact with the substrates.
To further our understanding of the catalytic mechanism
of TMPK, we have extended the structural work to the
human enzyme. We crystallized complexes of human
TMPK that represent different states along the reaction
coordinate. Here, we present the high-resolution struc-
tures of human TMPK in complex with TMP and ADP,
TMP and the ATP analog AppNHp (β,γ-imidoadenosine
5′-triphosphate), TMP with ADP and the phosphoryl
group mimic aluminum fluoride AlF3, ADP and TDP,
and TP5A (a bisubstrate/biproduct inhibitor). Our data
show the enzyme and nucleotides in different conforma-
tions. We correlate these changes with the different
states that occur during the enzymatic reaction. This
requires an extension of the minimal reaction scheme by
at least two additional steps for human TMPK.
Results
Human TMPK consists of 212 amino acid residues with a
calculated molecular weight of 24 kDa. It is a homo-
dimeric globular protein (Figure 1a) with a similar fold to
that described for the yeast and E. coli TMPKs [5,16].
Each monomer consists of a five-stranded parallel β-sheet
core surrounded by nine α helices. The highly hydropho-
bic dimer interface is generated by the stacking of three
nearly parallel helices from each monomer against each
other. The determinants of substrate specificity are
similar to those in yeast TMPK [4].
Substrate-induced conformational changes 
In all structures presented here both nucleotide-binding
sites are occupied, resulting in globally closed conforma-
tions of the enzyme. A novel feature observed in the
human TMPK structures concerns the additional confor-
mational changes that occur within this globally closed
conformation, which are dependent on the nature of the
bound substrates. This newly recognized feature entails
the rigid-body movement of three loop regions — the 
P-loop (residues 13–17), the LID (residues 135–150), and
the adenine-base binding loop (residues 178–188). Thus,
within the globally closed conformation we observe differ-
ent conformations for these regions (Figure 1b). The first
conformation, which we term ‘P-loop open’, is formed in
the presence of TMP and ADP. The second, the ‘P-loop
partially closed’ conformation, results when ADP is
replaced by AppNHp or when AlF3 is soaked into a
TMP–ADP crystal (1.1 Å movement measured at the Cα
atom of Asp15). The third state, the ‘P-loop closed’ con-
formation, is occupied when TP5A is present (2.1 Å move-
ment measured at the Cα atom of Asp15 compared with
the open conformation) or in the presence of the products
TDP and ADP. Although with each P-loop movement a
concomitant shift in the position of the LID region and
the adenine-base binding loop is also observed, we choose
the above terminology that focuses on the P-loop, because
of the importance of this loop and for clarity. It should be
kept in mind, however, that all three loops undergo 
630 Structure 2000, Vol 8 No 6
conformational changes upon transition between the differ-
ent states. The P-loop moves as a rigid body, with the
hinges being formed by two highly conserved residues:
Glu12, which anchors the P-loop via a bidentate interaction
with the hydroxyl (2.5 Å) and the amide (2.9 Å) groups of
Ser101, and Lys19, which interacts with the phosphate(s).
These conformational changes are not observed in other
structurally characterized NMPKs and seem to be unique
to TMPK. In the case of AMPK no P-loop conformational
change is observed between the complexes with AMP
and ADP (Protein Data Bank [PDB] accession code 2eck)
and with AMP and AppNHp [17]. Likewise, structural
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Figure 1
Rigid-body movements within the substrate-
bound, globally closed conformation of the
homodimeric human TMPK in response to the
nature of the bound substrates.
(a) Stereoview ribbon diagram of the globally
closed conformation of the TMPK dimer in
complex with TMP and AppNHp (substrates
in yellow; α helices in green or cyan, and 
β strands in red or magenta to differentiate
between monomers). Loops are depicted as
gray coils, except for the P-loop and LID
regions which are colored orange with black
Cα atoms. (b) Stereoview overlay of three
TMPK monomers to illustrate the different
conformations within the globally closed
conformation (root mean square deviation
[rmsd] for all Cα atoms except the colored
regions < 0.17 Å). The three regions that
undergo conformational changes — the P-loop,
LID and adenine base binding loop — are
colored. Within the globally closed
conformation we differentiate between an
open conformation that is formed when TMP
and ADP are bound (red), the partially closed
conformation in the presence of TMP and
AppNHp (yellow) and the fully closed state
when TP5A is bound (green). (c) Stereoview
close-up of the colored regions of (b) (same
orientation). Arg143 (orange) from the LID
region has a crucial role in the communication
between the regions that are involved in the
rigid-body movement. Arg143 forms a base-
stacking interaction with the adenine base
and hydrogen bonds to backbone carbonyl
oxygens of Arg16 of the P-loop and Ala180 of
the adenine base binding loop. The figures
were generated using the programs Molscript
[28] and Raster3D [29].
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comparisons of UMPK in complex with UMP and ADP in
the presence or absence of the transition-state analog
AIF3 shows no P-loop mainchain atom movement [15].
To the best of our knowledge, no P-loop movement in
GTP- or ATP-binding proteins has been observed upon
replacement of a diphosphate by a triphosphate.
As in other NMPKs, an arginine from the LID region
(Arg143) forms a stacking interaction with the adenine
base. The guanidinium group of this arginine also inter-
acts with the mainchain carbonyl oxygens of both Arg16 of
the P-loop (3.1 Å) and Ala180 (2.7 Å) of the third region
involved in the rigid-body movement (see above and
Figure 1c). Thus Arg143 seems to have a crucial role for
the communication between the base of the phosphoryl
donor and the three regions observed in different confor-
mations within the globally closed conformation.
The complex with TMP and ADP 
The structure of human TMPK in complex with TMP and
ADP shows the P-loop open conformation (Figure 2a). The
hydrogen-bonding network built by seven water molecules
located between the P-loop and the monophosphate seems
to be crucial in stabilizing this conformation. The 
3′-hydroxyl of the TMP ribose interacts with water mol-
ecule Wat510, which makes further interactions to other
waters (Wat512 and Wat790) that for their part interact with
protein residues (Arg97 and Gln157) and additional water
molecules. Wat512 connects Wat510 and Wat508, the latter
and Wat507 (which is coordinated to Mg2+) acting as ‘space
fillers’ for the γ-phosphoryl group in ATP. Further strongly
bound water molecules (511, 513 and 514 with very good
electron density and low B factors) are placed between the
P-loop and TMP such that they form hydrogen bonds to
both the P-loop and the sidechain of Arg97, a residue that is
involved in TMP binding. In the P-loop open conformation
the distance between the sidechain of Asp15 and the 
3′-hydroxyl of TMP is 6.8 Å. This is noteworthy because in
the ‘P-loop closed’ conformation this aspartate interacts
with the 3′-hydroxyl group (see below). As many nucleo-
side analogs with antiviral activity are modified at this posi-
tion (e.g., the azido group of AZT replaces the 3′-hydroxyl
of TMP), the interactions made by a 3′-substituent and the
enzyme are likely to be critical for the ability of the enzyme
to phosphorylate the analog. The TMP phosphoryl group is
positioned by two hydrogen bonds between OP2 and OP1
to Arg97 (2.7 Å and 2.9 Å to atoms NE and NH2, respec-
tively), and a water-mediated interaction (Wat509)
between OP3 and NH2 of Arg45 (2.2 Å and 2.7 Å, respec-
tively). In addition, each of the phosphate oxygen atoms
interacts with a water molecule that coordinates the ADP-
bound magnesium ion (distances between 2.7 Å and 2.9 Å).
The complex with TMP and AppNHp 
As the complex with TMP and AppNHp crystallizes iso-
morphously with the TMP and ADP complex, we used the
coordinates of the latter to start refinement. Upon inspec-
tion of the resulting electron-density map we observed
density at the expected position of a γ-phosphate.
However, the electron-density for the P-loop and LID
region was of inferior quality. Further refinement with
extensive use of omit maps revealed that the P-loop and
LID regions have two conformations: one previously seen
in the ADP complex, and an additional conformation
termed ‘P-loop partially closed’ (maximum backbone
movements of 1.4 Å and 2.3 Å Cα for the atoms of Val14
[P-loop] and Leu137 [LID], respectively). Therefore, the
electron density was interpreted as representing two states:
the first, with an occupancy of one-third, has ADP present
at the phosphoryl donor site and the P-loop and LID in the
open conformation, a conformation identical to that
described above for the TMP–ADP complex. The second
state, with an occupancy of two-thirds, has AppNHp at the
phosphoryl donor binding site and the P-loop and LID in
the partially closed conformation (Figure 2b). The observa-
tion of both ADP and AppNHp in the complex is probably
a result of using an ADP-bound enzyme preparation for the
crystallization setups. Despite following a purification pro-
tocol in which no nucleotides were present, the pure
TMPK contains approximately 20% TMP and ADP.
Attempts to obtain nucleotide-free enzyme were not suc-
cessful. To increase the occupancy of AppNHp, the crys-
tallization setups contained 20 mM of the ATP analog. An
alternative reason for the ADP observed might be the
hydrolysis of AppNHp during the crystallization proce-
dure. In this case, ADP–NH2, which would be indistin-
guishable from ADP, would be bound. The presence of
two states is consistent with high B factors for the γ-phos-
phate of AppNHp if modeled with an occupancy of one,
and its relatively weak density. Concomitant with the 
P-loop and LID, the region between residues Ala180 and
Val187 (maximal movement at Cα of Lys182 is 0.3 Å) and
AppNHp with its bound magnesium ion move towards the
monophosphate (0.2 Å). Although the magnitude of this
movement is close to the coordinate error, the displace-
ment seems to be significant as it includes a whole region
and not only a few uncorrelated atoms.
In addition to the mixture of ADP and AppNHp, we
observe the phosphoryl group of TMP in two conformations
(but with a single conformation for the base and ribose moi-
eties). In one conformation, the phosphoryl group is in the
same position as in the complex with TMP and ADP and is
modeled with an occupancy of one-third. The other confor-
mation, modeled with an occupancy of two-thirds, has the
phosphate group displaced (2.2 Å between the phosphate
atoms of the two states) and correlates with AppNHp
binding. Thus, in the presence of AppNHp, the phosphoryl
group of TMP does not interact with Arg97, but rather
forms a hydrogen bond (2.7 Å) with NH2 of Arg45. The
high-resolution and quality of our data enables us to observe
and estimate the partially occupied states quite accurately.
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The γ-phosphoryl group of AppNHp interacts with both
Arg97 NH2 (3.2 Å) and Lys19 NZ (2.8 Å) through the
oxygen atom O3P (Figure 2b). In addition to these interac-
tions, the P-loop partially closed conformation is stabilized
by many new interactions that are not observed in the 
P-loop open conformation. These include hydrogen bonds
between several pairs of residues: the sidechain of Asp15
and NH2 of Arg97 (2.7 Å); the sidechain of Asp15 and
Gln157 (2.9 Å); the amino group of the highly conserved
Lys19 and the backbone carbonyl of Val14 of the P-loop
(2.6 Å compared to 3.6 Å in the open conformation); and
the amide of Arg16 and the imido group between the 
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Figure 2
Comparison of the open and partially closed
active-site conformations of human TMPK
reveal the reasons for the P-loop closure upon
replacement of ADP by AppNHp. Nucleotides
and selected protein residues are shown in a
ball-and-stick representation, the magnesium
ion (magenta) is connected with thin dashed
lines to its six ligands. (a) Stereoview of the
open P-loop conformation of TMPK in
complex with TMP and ADP. The seven water
molecules (numbered cyan spheres) located
between the P-loop and TMP build a
hydrogen-bonding network that stabilizes the
open P-loop conformation. (b) Stereoview of
the partially closed P-loop conformation of
TMPK in complex with TMP and AppNHp.
New interactions (shown as thick dashed
lines) that are not possible in the open
conformation stabilize this conformation. 
(c) Stereoview overlay of (a) (red) and (b)
(yellow) shows that the γ-phosphoryl group of
AppNHp displaces two water molecules
(507 and 508) and induces the sidechain of
Asp15 to rotate towards the 3′-hydroxyl of
TMP. The rotation of Asp15 results in the
displacement of water molecules 510, 512
and 790. Thus, the binding of the γ-
phosphoryl group in AppNHp results in the
destabilization of the open conformation as it
induces the replacement of at least five water
molecules that are involved in the stabilization
of the open P-loop conformation.
Concomitantly, the partially closed
conformation is stabilized by interactions that
are not possible in the open conformation.
The figures were generated using the
programs Molscript [28] and Raster 3D [29].
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β- and γ-phosphates of AppNHp (3.1 Å versus 3.4 Å in the
open conformation). Whereas in the open conformation
the P-loop and LID interact directly (3.2 Å) via the amide
of Val14 and the carbonyl group of Leu133, this interaction
is broken in the partially closed state, where a water mol-
ecule (Wat511) bridges the two regions.
The TMP–ADP–AlF3 complex 
The P-loop partially closed conformation is also observed
in the presence of the phosphoryl group mimic AlF3 (see
Supplementary material), which is expected to simulate
the transition-state conformation based on earlier work
mainly on GTPases and ATPases (for a review see [18]).
In the TMP–ADP–AlF3 complex the distance between
OP5 of ADP — the leaving group atom during the phos-
phoryltransfer reaction — and the amide nitrogen of the
Arg16 of the P-loop is 2.9 Å. The TMP phosphoryl group
is in a position between that seen in the TMP–ADP- and
the TMP-AppNHp-bound states (Figure 3a). The phos-
phoryl group of TMP is placed such that the OP3 oxygen
atom makes a 2.9 Å interaction to NE of Arg97, and OP2
is at a distance of 3.5 Å from NH2 of Arg45. Importantly,
the TMP phosphate oxygen that points toward the AlF3
molecule makes no interaction with the enzyme and
seems to be in an optimal position for nucleophilic attack.
Precise modeling of AlF3 is difficult due to the ambigu-
ous electron density, consistent with the very weak affin-
ity (see Materials and methods). In the last step of the
refinement, we modeled the remaining positive Fo–Fc
difference electron density as AlF3, which is in line with
other structures determined at pH 8.0 [19].
The complex with TDP and ADP 
Because this complex was crystallized in the presence of
both substrates, a mixture of substrates and products would
be expected. However, at the phosphoryl donor site we do
not observe any density that would correspond to the 
γ-phosphate of ATP (ADP is therefore modeled with an
occupancy of one, and at the acceptor site, we observe pre-
dominately TDP (modeled with two-thirds occupancy,
one-third is modeled as TMP). In this complex the P-loop
and LID are in the fully closed conformation (maximal shift
of the P-loop between the open and closed conformation is
2.1 Å at the Cα atom of Asp15). Concomitant with the
P-loop and LID region, ADP with its associated magnesium
ion shifts by 0.5 Å in the direction of TDP, so that the dis-
tance between the leaving oxygen atom of ADP and amide
nitrogen of Arg16 remains at 2.9 Å. The carboxylate group
of Asp15 rotates by 30° compared with its position in the
complex with either TMP–AppNHp or TMP–ADP–AlF3,
and is in a position to make a bidentate interaction with the
3′-hydroxyl of TDP. The most pronounced conformational
changes in this complex, in comparison to the structures
described above, are a 90° rotation of the Arg97 sidechain
around the bond between atoms CG and CD, and a
rearrangement of the TDP phosphates (Figure 4). In the
TDP–ADP-bound conformation, NE of Arg97 hydrogen
bonds to the carbonyl oxygen of Phe42. The carbonyl group
of Phe42 is fixed at this position as the following amino acid
is a highly conserved cis-proline. This interaction may
explain why this residue adopts the cis conformation. At the
same time, the phosphoryl groups of TDP rearrange with a
3.8 Å shift of the α-phosphate of TDP in comparison to the
phosphate position of TMP in the AlF3 complex. The new
position of the phosphates is fixed by interactions between
the α-phosphate and Arg45 and two hydrogen bonds
between OP3 and OP4 of the β-phosphate and NH1 and
NH2 of Arg97 (2.9 Å and 2.8 Å, respectively). At the posi-
tion of Arg97 as seen in the other complexes, there are two
water molecules (Wat515 and Wat516) that act as space
fillers for the arginine sidechain in the product-bound
complex. These water molecules form hydrogen bonds to
the P-loop, thereby stabilizing this conformation.
Complex with TP5A 
The fully closed protein conformation observed in the
TP5A complex is similar to the protein conformation when
TDP and ADP are bound. However, Arg97 is not in the
rotated conformation but remains in the position seen in the
AppNHp and AlF3 structures, due to the covalently linked
phosphate chain of the nucleotide analog that prevents such
a rotation. In this conformation the distance between OD1
of Asp15 and NH2 of Arg97 is 2.2 Å, and the distance
between OD1 of Asp15 and O2G of the middle phosphoryl
group of TP5A is 3.0 Å. The O2G of TP5A interacts with
basic residues that may shield the negative charge (3.0 Å
and 2.9 Å to Lys19 NZ and Arg97 NH2, respectively).
Despite the lack of electron density for the additional
phosphoryl group — the one bridging TMP and ATP in
TP5A — and despite only poor density for the middle
phosphoryl group of TP5A, the presence of TP5A in the
crystals was established for the following reasons. First, we
observe the fully closed conformation of TMPK (in the
presence of TMP and ADP we observe the open confor-
mation). Second, we determined the Kd of the complex of
TP5A and human TMPK to be 210 ± 30 nM, allowing the
formation of a stoichiometric complex under the crystal-
lization conditions (concentrations of TMPK and TP5A
were 1 mM and 2 mM, respectively). Third, high pressure
liquid chromatography (HPLC) analysis of dissolved crys-
tals unambiguously demonstrated the presence of TP5A. 
Discussion
NMPKs are highly flexible molecules that undergo large
conformational changes upon substrate binding [12]. In
the presence of both nucleotides, these enzymes occupy a
closed conformation. The structures of the surface mutant
Arg200→Ala of human TMPK presented herein (the
Arg200→Ala mutant has identical kinetic and structural
properties to wild-type TMPK, see the Materials and
methods section) show that this kinase makes additional
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conformational changes within a globally closed conforma-
tion that are dependent on the nature of the bound
nucleotides. At this stage we cannot be sure whether this
novel feature is unique to the human enzyme, or if it is a
general feature of all TMPKs. In the following discussion
the forward reaction (i.e., the production of ADP and
TDP from ATP and TMP) will be considered, but it
should be kept in mind that the overall reaction is
reversible with an equilibrium constant near to unity.
The γ-phosphoryl group of AppNHp induces P-loop closure
The structure of TMPK in complex with TMP and ADP
(a combination of substrate and product) shows an open
conformation of the P-loop, the LID, and the adenine-
binding region. Upon binding of the ATP analog
AppNHp these three regions undergo concerted rigid-
body movements, with the communication between the
regions occurring mainly through Arg143. This residue is
located in the LID region (Figure 1c) and forms a base-
stacking interaction with the adenine base and hydrogen
bonds to the backbone carbonyl oxygen atoms of Arg16 in
the P-loop and Ala180 in the adenine-binding region.
The open P-loop conformation appears to be stabilized by a
hydrogen-bonded network of water molecules that are
located between the P-loop, Gln157 and TMP. Replace-
ment of ADP by AppNHp induces a conformational
change to a partially closed P-loop conformation
(Figure 2c), which can be rationalized by the following sce-
nario. Upon binding, the γ-phosphoryl group of AppNHp
displaces Wat507, which is coordinated to the magnesium
ion when ADP is bound, and Wat508. Thus, these water
molecules function as space fillers for the γ-phosphoryl
group in the TMP–ADP complex. In addition, the pres-
ence of the γ-phosphoryl group of AppNHp causes the
sidechain of Asp15 to rotate towards the 3′-hydroxyl group
of the TMP ribose, but without approaching closely
enough for an interaction to occur. The change in the
Asp15 sidechain position results in the displacement of five
more water molecules (510, 512, 513, 514 and 790), two of
which (510 and 512) function as space fillers for the new
Asp15 conformation. In this orientation, Asp15 interacts
directly (and not via Wat514) with the sidechain carbonyl
oxygen of Asn157, and the guanidinium group of Arg97.
These interactions are made possible by the movement of
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Figure 3
The different ways of positioning the
phosphoryl groups of TMP and AMP by TMPK
and AMPK, respectively, reveal the reasons
for unique movements of the TMP phosphoryl
group in the different TMPK complexes.
(a) Stereoview overlay of TMP, Arg97 and
Arg45 of the complexes of TMPK with TMP
and ADP (red), TMP and AppNHp (yellow)
and TMP with ADP and AlF3 (green). AppNHp
is shown to give the orientation for the
nucleophilic attack of the monophosphate. It
is only in the AIF3 structure that the TMP
phosphoryl group is in an optimal position for
nucleophilic attack on the phosphoryl group
to be transferred. (b) Stereoview positioning
of the AMP phosphoryl group of AMPK in
complex with AMP and AppNHp. In contrast
to TMPK the AMP phosphoryl group is fixed in
an optimal position for the nucleophilic attack
by two additional arginine residues that are
not present in TMPK. Two of the three oxygen
atoms of the AMP phosphoryl group are
hydrogen bonded to Arg88 and Arg36
(homologous to Arg97 and Arg45 in TMPK).
In addition, Arg156 from the LID region makes
an interaction to one oxygen atom of the AMP
phosphoryl group and Arg167 is 3.6 Å from
the attacking oxygen, leaving it free for the
nucleophilic attack. The figures were
generated using the programs Molscript [28]
and Raster 3D [29]. 
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the P-loop to the P-loop partially closed conformation.
Therefore, the shift from the open P-loop conformation to
the P-loop partially closed conformation is a consequence
of the break in the water structure that stabilizes the open
conformation and of the formation of new interactions only
possible in the partially closed conformation.
Any valid mechanistic interpretation of the structure with
AppNHp bound is dependent on it being a good ATP
analog for TMPK. In the TMP–AppNHp complex, the
lone electron pair of the bridging imido group between
the β- and γ-phosphoryl group interacts (distance 3.1 Å)
with the amide of Arg16 located in the P-loop. An analo-
gous interaction is seen in all P-loop-containing enzymes
the structures of which have been determined in the
triphosphate-bound state. This interaction is important for
stabilizing the negative charge that arises at the leaving
oxygen atom (the atom that bridges the β- and γ-phos-
phates) during the phosphoryltransfer reaction. Therefore,
a correlation between the chemical nature of the bridging
group and the P-loop conformation is of great mechanistic
importance (see below). The recent analysis of p21ras com-
plexed with GppNHp or with GTP shows no significant
difference between the two structures either in the P-loop
conformation or the nucleotide position [20]. This
detailed analysis led to the conclusion that in the case of
p21ras, GppNHp is a good GTP analog. However,
AppNHp is not a good analog of ATP in all systems. The
best documented example is myosin ATPase, where it has
been shown that AppNHp binds many orders of magni-
tude more weakly than ATP and is only able to mimic
some of the consequences of ATP binding in physiologi-
cal and biochemical experiments. This appears to be due
to the fact that, in this system, correct binding of ATP
requires not only a P-loop backbone interaction with the
bridging β,γ-oxygen but also an interaction of this oxygen
with an asparagine sidechain [21]. This is not possible
with AppNHp. If such an interaction were important for
TMPK, it might be expected to be seen in the AlF3
complex, which is not the case. In addition, the affinity of
TMPK for AppNHp, although lower than for ATP, is only
reduced by a factor of 30 (NO et al., unpublished results),
similar to the situation for p21ras. On the basis of these
considerations, we conclude that AppNHp is a valid ATP
analog in the case of TMPK, and that the observed P-loop
partially closed conformation is mechanistically important.
We designate the P-loop partially closed conformation as
an active conformation in the sense that it is structurally
close to the active ground state of the forward reaction
(defined here as the state immediately preceding attack
of the phosphate of TMP on the β-phosphate of ATP)
for the following reasons. First, P-loop closure is only
observed in complexes with nucleotides that allow the
aforementioned interaction between the β- and γ-phos-
phate bridging atom and the P-loop. (In the structure of
TMPK in complex with AppCH2p the P-loop is in the
open conformation; NO et al., unpublished results). In
complexes of human TMPK with AppNHp and the sub-
strate TMP, the P-loop is partially closed whereas it is
fully closed upon replacement of TMP by the substrate
analog 3′-amino-3′-deoxythymidine monophosphate
(NO et al., unpublished results). Thus, the AppNHp
imido group does not prevent P-loop closure, which
strongly suggests that the P-loop partially closed confor-
mation is mechanistically important. Second, in the AlF3
complex, a state that could be interpreted to mimic
aspects of the transition-state conformation, the P-loop is
also in the partially closed conformation. Third, a corre-
lation has been established between the ability of the
enzyme to adopt the P-loop partially closed conforma-
tion and the in vitro steady-state phosphorylation rate
with different TMP analogs (NO et al., unpublished
results). Fourth, the critical distance between the amide
of Arg16 and the atom corresponding to the bridging
atom between the β- and γ-phosphoryl groups in ATP
(2.9 Å in AlF3, 3.1 Å in AppNHp and 3.4 Å in ADP)
shortens. Fifth, in the P-loop partially closed conforma-
tion, the carboxylic sidechain of the P-loop Asp15 inter-
acts with the sidechains of the highly conserved Gln157
636 Structure 2000, Vol 8 No 6
Figure 4
Conformational changes of Arg97 and the
phosphoryl groups of TDP to the stable
product conformation in the TDP–ADP bound
complex. Overlay of the TMP/TDP-binding site
of the structures of TMPK in complex with
TMP, ADP and AlF3 (red) and TDP and ADP
(yellow). In the complex with bound TDP and
ADP the sidechain of Arg97 rotates (90°)
around the bond between the atoms CG and
CD such that it cannot act as a clamp to bring
both nucleotides together for the backward
reaction. The figures were generated using the
programs Molscript [28] and Raster 3D [29]. 
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and Arg97. The latter interaction may have an important
role in positioning this catalytic arginine and may also
prevent an interaction with the attacking oxygen atom of
the TMP phosphate group (as observed in the P-loop
open state) by neutralizing its charge.
AlF3 brings both TMPK and the substrates into an active
conformation 
Despite strong electron density for the AIF3 moiety
between the nucleotides, the density is not well defined,
making the precise modeling of this group difficult.
Therefore, it is not clear whether the quaternary
complex of TMPK with TMP, ADP and AlF3 reflects
the structure of the transition state of the reaction, the
Michaelis complex, or an activated ground state. It is
highly probable, however, that of all the states described,
it is closest in structure to the transition state.
The complex of TMPK with TMP, ADP and AlF3 is
interpreted as representing not only the active enzyme
conformation (partially closed P-loop) but also the active
conformation of the nucleotides. An overlay with the other
structures shows that the protein structure is nearly identi-
cal to that seen in the complex with TMP and AppNHp.
The P-loop moves slightly further towards the monophos-
phate, but all interactions are the same. Analysis of the dif-
ferent positions observed for the phosphate group of TMP
in the structures presented here indicates that only in the
AlF3-bound state does the phosphoryl group adopt what
appears to be an optimal position for a nucleophilic attack
on the phosphoryl group to be transferred (simulated by
AlF3 in this case; Figure 3a). In the AlF3 complex, the
phosphate group of TMP makes only one interaction with
Arg97, leaving the attacking oxygen atom free for nucle-
ophilic attack on the γ-phosphate of ATP. In contrast, this
phosphate oxygen atom forms a double interaction with
Arg97 in the TMP–ADP-bound conformation, so that the
negative charge would be partially shielded, making it a
weaker nucleophile. Likewise, the TMP phosphate con-
formation observed in the TMP–AppNHp complex is not
favorable for catalysis as the distance between the attack-
ing oxygen and the phosphorous atom of the phosphoryl
group to be transferred is longer than that seen in the AlF3
conformation. We attribute this observation to the repul-
sion between the negatively charged oxygen atoms in
TMP and the γ-phosphoryl group of AppNHp. Therefore,
we only regard the TMP conformation in the AlF3
complex as the active conformation for this nucleotide.
The TDP–ADP product complex 
Crystallization of TMPK in the presence of the substrates
TMP and ATP results in a fully closed conformation of the
protein complexed with the products TDP and ADP, which
are, of course, the substrates for the reverse reaction. Ques-
tions that must be asked at this point are why only the
product complex is seen in the structure and whether this
complex is on the normal catalytic pathway. Concerning the
lack of electron density corresponding to the substrates, one
must consider the following. The equilibrium constant for
phosphate transfer is approximately unity in solution and
presumably similar in the protein. A relatively small depar-
ture (in energetic terms) from this value in the direction of
product formation could lead to a situation in which a minor
population of the substrate complex would not be detected
in the crystal structure. The departure from the value of the
equilibrium constant for the free nucleotides in solution is
therefore interpreted as the effect of the active site of the
enzyme, perhaps combined with some effect of crystal
packing forces. For the sake of present arguments, we
assume that the observed conformation is on the reaction
pathway. In the forward direction we interpret it to repre-
sent a state after phosphate transfer and before product
release. The law of microscopic reversibility requires that
the reaction pathway traversed in the forward reaction is also
taken in the reverse direction, under identical conditions.
Thus, if the structure of the complex with AlF3 is consid-
ered to represent, or at least to approach, the transition-state
structure for the forward reaction, it must serve the same
function for the back reaction. (This interpretation is based
on the assumption that the mechanism does not involve a
discrete covalent intermediate; in such a case, two transition
states are expected.) The product conformation we observe
is very different from the conformation of the presumed
transition-state complex analog seen with AIF3, implying
that a conformational change takes place after the chemical
step (Figure 4). This means, in turn, that the structure we
have characterized cannot be regarded as being the state
immediately preceding attack of the β-phosphate of ADP
on the β-phosphate of TDP in the back reaction. In keeping
with this, the conformation observed appears to lack vital
interactions required for catalysis because of a rotation of
the diphosphate moiety of TDP with respect to the phos-
phate position when TMP is bound. As a result, the β-phos-
phoryl group of TDP (the transferred phosphoryl group)
does not interact with the catalytic magnesium ion, but
rather forms two hydrogen bonds to Arg97, which rotate
concomitantly to a position very close to that previously
occupied by the phosphate group of TMP. In the new posi-
tion Arg97 cannot act as a clamp to bring the nucleotides
together (as seen in the AlF3 complex). Wat515 and Wat516
bind at the ‘old’ positions of the NH1 and NH2 atoms of
Arg97, respectively, thereby preserving the Arg97 interac-
tions (e.g., with the hydroxyl group of Ser101 or with the
Asp15 carboxyl oxygen atom). The other carboxyl oxygen
atom of Asp15 interacts with the 3′-hydroxyl of the TMP
ribose and the amino group of the Gln157 sidechain.
The TMPK–TP5A complex resembles the active
enzyme–product conformation 
Phosphate-linked dinucleotide inhibitors such as AP5A,
UP5A or TP5A have been extensively utilized in studies
of NMPKs as transition state, bisubstrate or biproduct
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mimics [5,14,16,22]. A complex of AMPK and AP5A was
interpreted to simulate the substrate-bound conformation
[23], whereas for UMPK the analogous complex with
UP5A was interpreted as representing the product-bound
conformation rather than the substrate-bound state [14].
The overlay of the human TMPK–TP5A structure with
the other structures shows that the protein conformation is
nearly identical to that seen in the TDP–ADP complex
(interpreted as an isomerized product complex). The only
difference in protein structure between the complexes is
the orientation of the Arg97 sidechain. This residue
adopts the same conformation as in the ADP, AppNHp or
AlF3 complex and interacts with the γ-phosphate of the
ATP moiety of TP5A. The interaction between the P-loop
carboxylic acid and the 3′-hydroxyl of TDP in the
TDP–ADP complex structure, or to the corresponding
atom in the presence of TP5A, is nearly identical and quite
different from that seen in the other structures. There is
no electron density for the phosphate group linking the
ATP and TMP moiety in TP5A, and the temperature
factors for the terminal phosphates of ATP and TMP are
high. Therefore, and because of the high similarity in the
protein structures of the TDP–ADP and TP5A complexes,
we interpret the TP5A-bound complex as the enzyme con-
formation immediately after the phosphoryltransfer but
prior to the conformational change to the product confor-
mation discussed above.
What is the role of Arg16? 
The P-loop of all eukaryotic TMPKs contains an arginine
residue that follows the strictly conserved carboxylic acid.
In the yeast TMPK–TP5A complex, an interaction
between the sidechain of Arg15 and the middle phosphate
group of the inhibitor was observed. Taken together with
the result that mutating this arginine to glycine in the
yeast enzyme reduces the activity 200-fold [7], we
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Figure 5
(a) The minimal scheme for a bi-bi mechanism
requires an expansion to account for the
conformational changes that occur after both
substrates are bound and prior to product
release. We have proposed these states, I, II,
III and IV, on the basis of the different
structural features observed in the different
complexes of human TMPK (b), labeled A, B,
C and D: (A) overlay of the TMP–ADP (gray)
and TMP–AppNHp (yellow) complexes; (B)
TMP–AppNHp and TMP–ADP–AlF3 (green);
(C) TMP–ADP–AlF3 and Tp5A (blue; theβ-phosphate group of Tp5A is modeled; (D)
Tp5A and TDP–ADP (red). Superposition of
the different states reveals the possible
dynamics that occur during the
phosphoryltransfer reaction. Note that the
TMP–ADP complex shown in (A) does not
represent a state on the reaction coordinate,
but rather reveals the conformational changes
that occur upon the replacement of a
diphosphate by a triphosphate at the
phosphoryl donor site.
assigned a catalytic role to this residue [16]. In all of the
human TMPK complex structures, however, we observe
this arginine in an extended conformation that precludes
interaction with the phosphates. This result is consistent
with mutagenesis experiments that show no appreciable
decrease in catalytic rate upon mutating this residue to
glycine [7]. Interestingly, the rate observed for the human
enzyme (0.7 sec–1) is similar to that measured for the yeast
enzyme lacking this residue (35 sec–1 for wild type,
0.2 sec–1 for the Arg15→Gly mutant [7]). Thus, a critical
difference between the yeast and the human enzymes
(44% sequence identity) seems to be the role of the P-loop
arginine, which seems to be catalytically important only in
the yeast enzyme. It should be pointed out, however, that
this interpretation is not conclusive, as there is as yet no
available evidence concerning the identity of the rate-lim-
iting step in these enzymes, so definitive assignment of
the roles of individual amino acids in catalysis based on
mutagenesis experiments is not yet possible.
In comparison to AMPK or UMPK, TMPKs contain two
fewer arginine residues that can potentially interact with
the transferred phosphoryl group. Such an interaction,
made by positively charged residues, would act to stabi-
lize the transition state. Notably, of these two arginines in
the human TMPK, Arg15 and Arg97, only the latter is
seen to interact with the phosphate that would correspond
to the γ-phosphate of ATP. One possible explanation for
this observation is that in vivo an additional factor inter-
acts with human TMPK and can induce the P-loop’s argi-
nine to make the above mentioned interaction, and
possibly also contributes an additional arginine to the
active site. Such a scenario would be similar to the situa-
tion in p21ras where GTPase-activating protein (GAP), in
addition to assembling the residues at the active site, pro-
vides a catalytic residue. This is an attractive possibility
because the activity of isolated human TMPK is in fact
very low. Thus, such a factor would add another level of
control in addition to transcriptional control.
Interpretation of the structures as snapshots along the
reaction coordinate 
The structures can be pieced together as snapshots in a
‘catalytic movie’ used to analyze the phosphoryltransfer in
the forward reaction and to deduce the dynamics of the
reaction. The following is an interpretation of the structures
presented pinpointing the likely conformational changes,
for both enzyme and nucleotides, that occur during the
overall phosphoryltransfer reaction. Making the assumption
that human TMPK operates by a bi-bi mechanism to cat-
alyze phosphoryltransfer, as demonstrated for mouse
TMPK [9], for AMPK [11] and GMPK [10], we can draw
the simple reaction scheme shown in Figure 5a. Our struc-
tures of human TMPK, however, suggest that this reaction
scheme should be extended by at least two steps in order to
account for the different conformations observed.
As we lack structural information on the free and singly
bound enzyme, the opening scene is represented by the
TMP and AppNHp complex structure (state A Figure 5b).
The P-loop and LID have already undergone a conforma-
tional change from the open form to the P-loop partially
closed state. However, in this state the TMP phosphoryl
group is not ideally positioned for nucleophilic attack on
the γ-phosphate of ATP. Therefore, we hypothesize that
before the chemical step can take place the TMP phospho-
ryl group swings away from Arg45 towards Arg97 and the
phosphate group of ATP, shortening the distance to the
donor nucleotide (state B Figure 5b). Arg97 now acts as a
clamp to bring the donor and acceptor nucleotides together.
As a model for the transition state of the chemical step, we
use the structure of the complex with bound AlF3. In this
state, the oxygen of the TMP phosphoryl group is opti-
mally positioned for attack on the γ-phosphate of ATP. 
As the phosphoryltransfer takes place, the P-loop and 
LID adopt the fully closed conformation, and the 
P-loop Asp15 enhances its interaction with the 
3′-hydroxyl of TMP. The TP5A complex structure is
interpreted to represent the enzyme conformation just
after the reaction has taken place (state C Figure 5b). This
state is probably only observable because of the restraints
imposed by using the covalently linked phosphate chain
in TP5A. Without this constraint, the phosphate groups of
TDP and the sidechain of Arg97 rotate to the stable
product conformation (state D, Figure 5b) represented by
the complex with TDP and ADP. As in the TP5A
complex, the enzyme adopts a fully closed conformation.
Biological implications
The structures of various complexes between human
thymidylate kinase (TMPK) and nucleotides presented
here detail the enzyme and nucleotide conformational
changes that occur during catalysis. Despite the limit
imposed by the technique of monochromatic X-ray
crystallography used in these studies, where only static
structures are observed, combining the information
from several structures provides valuable information
for understanding the dynamics of the reaction.
In the presence of bound nucleotides, the active site of
human TMPK adopts a globally closed conformation, as
seen earlier for adenylate kinase (AMPK) and uridylate
kinase (UMPK). In contrast to these two enzymes,
however, further structural changes at the active site
appear to be required for catalysis in human TMPK. It
seems likely that these processes limit the overall cataly-
sis rate of human TMPK, which in its isolated state is
several orders of magnitude less efficient than AMPK,
UMPK or even the highly homologous yeast TMPK.
Therefore, the question arises as to whether a mecha-
nism or factor is present in the cell for acceleration of this
surprisingly slow reaction. This could involve covalent
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modification 
(e.g., phosphorylation) or interaction with a protein
factor which favours the catalytically competent struc-
ture of the active site, or even supplies further catalytic
residues. Such a factor or mechanism would add another
level of control to the activity of the protein, in addition to
that of cell-cycle-dependent transcriptional control.
Materials and methods
Protein purification and crystallization 
Human TMPK (wild type and the Arg200→Ala-mutant) was
expressed as a GST fusion protein essentially as described previously
[7] and purified to homogeneity by GST affinity chromatography fol-
lowed by gel filtration. Crystals of human TMPK in complex with
nucleotides (TMP and ADP, TMP and AppNHp, TDP and ADP, and
the bisubstrate inhibitor TP5A) were grown by the vapor diffusion
method using the hanging-drop geometry. After formation of the
respective complex by mixing the nucleotides (end concentrations of:
1 mM TMP and ADP; 1 mM TMP and 20 mM AppNHp; 1 mM TMP
and 20 mM ATP; 2 mM TP5A) and the enzyme solution (28 mg ml–1
TMPK, 50 mM MgCl2, 200 mM KCl, 50 mM Tris/HCl pH 8.0), 2 µl of
the premixed solution was added to 2 µl of the reservoir solution
(15–22 % w/v PEG 3350, 5% v/v of sterile filtered dead sea water,
and 100 mM Tris/HCl pH 8.0 and left to equilibrate (at 20°) against
the reservoir. Typically, crystals grow within one to two weeks to
dimensions of 500 × 300 × 300 µm3. As cocrystallization with 1 mM
AlF3, 10 mM NaF did not result in additional electron density at the
active site, the TMPK complex with TMP, ADP and AlF3 was prepared
by soaking crystals of TMPK containing the nucleotides TMP and
ADP overnight in 85 mM AlCl3, 250 mM NaF. This procedure resulted
in additional electron density at the active site and a decrease of the
high-resolution diffraction to 2.0 Å. The complex of TMPK with TDP
and ADP was obtained in the presence of the substrates TMP and
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Table 1
Data collection and refinement statistics.
TMP–ADP TMP–AppNHp TMP–ADP–AlF3 TDP–ADP TP5A
X-ray source NSLS, X25 DESY, BW7B ESRF, ID14,3 rot. anode DESY, X11
Wavelength (Å) 1.100 0.847 0.931 1.54 0.9076
Detector B4-CCD MAR345 MAR CCD MAR345 MAR345
Temperature (K) 100 100 100 100 100
Data collection statistics
Space group P43212 P43212 P43212 P43212 P43212
Unit cell (Å)
a = b 101.0 101.3 101.6 101.1 101.1
c 49.8 49.3 49.3 49.2 49.3
Resolution (Å) 1.63 1.6 1.9 1.7 1.7
Observed reflections 325,999 103,211 106,992 139,922 148,714
Unique reflections 31,064 33,305 20,787 28,445 27,940
Completeness (%)
Overall/last shell 95.7/75.3 96.6/98.0 99.4/99.5 99.4/99.6 97.4/89.3
Rsym* (%)
Overall/last shell 6.1/20.3 4.6/15.5 7.5/46.3 5.2/29.6 3.3/22.2
Molecules/asymmetric unit 1 1 1 1 1
Refinement statistics
Resolution range (Å) 33.5–1.65 71.7–1.6 71.8–2.0 50.5–1.7 35.3–1.7
Reflections with F > 0σ
Working 27897 29949 16955 25586 25079
Test 3109 3355 930 2859 2772
Rcryst† (%) 20.1 19.8 21.4 19.1 19.2
Rfree‡ (%) 24.2 23.6 27.2 24.0 23.0 
No. of protein atoms§ 1647 1709 1617 1627 1646
No. of nucleotide atoms§ 48 100 48 / 4 73 52
No. of water atoms 293 300 173 277 250
No. of magnesium ions# 3 2 2 2 2
Rms deviations
bond lengths (Å) 0.012 0.011 0.018 0.012 0.012
bond angles (°) 1.6 1.7 1.6 1.3 1.5
Average B (Å2)
mainchain 17.6 21.9 38.8 22.2 24.5
sidechain 21.1 26.4 42.0 26.1 28.2
water molecules 30.7 39.5 51.9 38.3 38.7
nucleotides 16.9 20.1 40.0 / 64.0 19.8 25.0
magnesium ions 22.9 21.0 39.5 22.0 25.0
*Rsym = Σ|Iobs–<I>|/Σ<I>. †Rcryst = Σ|Fobs–Fcalc|/ΣFobs. ‡Rfree = Rcryst,
calculated for randomly selected reflections not included in the
refinement. §Number includes residues modeled in double
conformations and residues modeled as alanine if no electron density
for the sidechain is observed; for details see PDB header. In the case
of the AlF3 complex, 48 nucleotide atoms and the four atoms of AlF3
were modeled. #Only one of the metal ions is bound to ADP/ATP.
ATP in the crystallization solution with a 20-fold excess of ATP over
TMP to shift the equilibrium between TMP and TDP towards the
product TDP in solution. The idea to crystallize the product complex
using the substrates TMP and ATP as starting material arose from
observations made when crystallizing TMPK in complex, with TMP
and the ATP analog ATPγS (in ATPγS one oxygen atom of the γ-phos-
phoryl group of ATP is replaced by a sulfur atom). In the latter
complex, no electron density for the γ-phosphoryl group of ATPγS
was detectable, but instead we observed electron density for a
second phosphoryl group on the TMP site (NO et al., unpublished
results). We interpret the electron density as TDPβS and ADP.
Data collection and structure determination 
X-ray data were collected at 100K from liquid nitrogen flash-cooled crys-
tals using 10% xylitol and 10% glucose as cryoprotectant. The X-ray
sources and detectors used for data collection are listed in Table 1. Data
were processed with XDS [24] and merged with XSCALE.
The structure of human TMPK was solved by the molecular replace-
ment method with the program AMoRe [25] — thereby also establishing
the correct enantiomorph of the space group, which contains one
monomer per asymmetric unit — with the yeast TMPK coordinates (all
residues modeled as alanine) as search model. Refinement using the
rigid-body and simulated annealing protocols as implemented in
X-PLOR [26] resulted in a model used to calculate the initial electron-
density map, which was of high quality and allowed the unambiguous
assignment and building of most sidechains using the program O [27].
Electron density for both nucleotides (TMP and ADP) and the catalytic
magnesium ion was observed, but only modeled after most of the
protein mainchain and sidechain atoms were built and refined. We
noticed that the sidechain of Arg200 (not a conserved residue) from a
symmetry-related molecule (not the second monomer of the active
dimer) interacts with the β-phosphate of ADP. To avoid this crystal-
packing interaction with the nucleotides — which would complicate any
interpretation — we mutated Arg200 to alanine. As steady-state analy-
sis of the Arg200→Ala mutant yields identical results to that performed
with wild-type TMPK (kcat 0.7 s–1), and as the structures of both con-
structs in complex with TMP and ADP are identical within the coordi-
nate errors, all subsequent crystallographic experiments were
performed with the Arg200→Ala mutant. The final model of the
complex of TMPK with TMP and ADP was used as starting model for
the refinement of all other complexes reported here. After an initial sim-
ulated annealing step (T = 3000K) using X-PLOR [26], the refinement
(including individual temperature factors) was carried on with
PROTEIN/REFMAC [25]. The occupancies of alternative conforma-
tions and of the nucleotides were derived visually using SigmaA-
weighted mFobs–DFcalc electron-density maps [25]. The refinement
statistics are summarized in Table 1.
As the electron-density map of TMPK crystallized in the presence of TMP
and AppNHp shows a mixture of ADP and AppNHp bound at the phos-
phoryl donor-binding site (both modeled with an occupancy of 0.5), we
repeated the crystallization using the micro-seeding technique. This pro-
cedure reduces the time for crystal growth to two days so that hydrolysis
of AppNHp in the crystallization solution is reduced. The crystals were
immediately flash cooled and a second data set was collected. The
refined structure of this data set also shows a mixture of ADP and
AppNHp bound at the phosphoryl donor site with the P-loop and LID in
two conformations. However, the occupancy of AppNHp and the corre-
sponding conformations of the P-loop, LID and the phosphoryl group of
the monophosphate were determined to be two-thirds. This additional
experiment proves that the different conformations of the P-loop, LID and
the TMP phosphoryl group correlate with the presence of a diphosphate
or triphosphate at the ATP-binding site (see results).
Accession numbers
Coordinates of the human TMPK complex structures and the corre-
sponding structure factors have been deposited in the Protein Data
Bank with entry codes 1e2q (TMP–ADP), 1e2f (TMP–AppNp), 1e2e
(TMP–ADP–AlF3), 1e2g (TDP–ADP) and 1e2g (TP5A).
Supplementary material
Supplementary material including a stereoview of the nucleotides
observed in the TMP–ADP–AlF3 complex and a discussion on the role
of Asp15 is available at http://current-biology.com/supmat/supmatin.htm.
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